Pandanus amaryllifoius Roxb. Leaves Ethanol Extract Ameliorates Lipid and Proinflammatory Cytokines Profiles in a Rat Model of Dyslipidemia

키워드

참고문헌 (40)

1. Kwon SH, "Association between morbidity of non-communicable disease and employment status : a comparison between Korea and the United States", BMC Public Health, 20(1), pp.763~ (2020)
2. Cavalcanti AM, "Noncommunicable diseases and their common risk factors in Curitiba, Brazil : results of a crosssectional, population-based study", Rev Panam Salud Publica, 42, pp.e57~ (2018)
3. Crovetto M, "Relationship between dietary energy intake, nutritional status and cardiovascular risk in adults from the communes of Quellón and Chonchi, Chiloé, Chile", J Prev Med Hyg, 63(3), pp.E435~E441 (2022)
4. Pirillo A, "Global epidemiology of dyslipidaemias", Nat Rev Cardiol, 18(10), pp.689~700 (2021)
5. Poropat Flerin T, "Association between lipoprotein subfractions, hemostatic potentials, and coronary atherosclerosis", Dis Markers, 2022, pp.2993309~ (2022)
6. Fatkhullina AR, "The role of cytokines in the development of atherosclerosis", Biochemistry(Mosc), 81(11), pp.1358~1370 (2016)
7. Welz AN, "Why people use herbal medicine : insights from a focus-group study in Germany", BMC Complement Altern Med, 18(1), pp.92~ (2018)
8. Chiabchalard A, "Antihyperglycemic effects of Pandanus amaryllifolius Roxb. leaf extract", Pharmacogn Mag, 11(41), pp.117~122 (2015)
9. Laluces HM, "Antimicrobial alkaloids from the leaves of Pandanus amaryllifolius", J Appl Pharm Sci, 5(10), pp.151~153 (2015)
10. Ooi LS, "Purification and characterization of a new antiviral protein from the leaves of Pandanus amaryllifolius(Pandanaceae)", Int J Biochem Cell Biol, 36(8), pp.1440~1446 (2004)
11. Thanebal SA, "PP", Hepatoprotective effects of Pandanus amaryllifolius against carbon tetrachloride(CCl4)induced toxicity : a biochemical and histopathological study, 2021, pp.14(10), 103390~
12. Reshidan NH, "The effects of Pandanus amaryllifolius(Roxb. )leaf water extracts on fructoseinduced metabolic syndrome rat model", BMC Complement Altern Med, 19(1), pp.232~ (2019)
13. Lumbanraja MP, "Alkaloids from Pandanus amaryllifolius Roxb leaf as promising candidates for antidyslipidemic agents : an in silico study", Pharmacogn J, 15(1), pp.106~111 (2023)
14. Dewi RT, "Quality control standardization of Indonesian noni fruit(Morinda citrifolia)extract and evaluation of their angiotensin-converting enzyme inhibitory activity", Pharmacia, 69(3), pp.709~717 (2022)
15. Takayama H, "Structure characterization, biomimetic total synthesis, and optical purity of two new pyrrolidine alkaloids, pandamarilactonine-A and-B, isolated from Pandanus amaryllifolius Roxb", J Am Chem Soc, 122(36), pp.8635~8639 (2000)
16. Sikaris KA, "The clinical biochemistry of obesity", Clin Biochem Rev, 25(3), pp.165~181 (2004)
17. Buettner R, "High-fat diets : modeling the metabolic disorders of human obesity in rodents", Obesity(Silver Spring), 15(4), pp.798~808 (2007)
18. Tsai YC, "Alkaloids from Pandanus amaryllifolius : isolation and their plausible biosynthetic formation", J Nat Prod, 78(10), pp.2346~2354 (2015)
19. Ghasemzadeh A, "Profiling of phenolic compounds and their antioxidant and anticancer activities in pandan(Pandanus amaryllifolius Roxb. )extracts from different locations of Malaysia", BMC Complement Altern Med, 13, pp.341~ (2013)
20. Jeong SM, "Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db", db mice, 2012, pp.6(3), 201~207
21. Talirevic E, "Quercetin in the treatment of dyslipidemia", Med Arh, 66(2), pp.87~88 (2012)
22. Liu RH, "Potential synergy of phytochemicals in cancer prevention:mechanism of action", J Nutr, 134(12 Suppl), pp.3479S~3485S (2004)
23. Lin D, "An overview of plant phenolic compounds and their importance in human nutrition and management of type 2 diabetes", Molecules, 21(10), pp.1374~ (2016)
24. Desgagné-Penix I, "Distribution of alkaloids in woody plants", Plant Sci Today, 4(3), pp.137~142 (2017)
25. Larbat R, "Organspecific responses of tomato growth and phenolic metabolism to nitrate limitation", Plant Biol(Stuttg), 14(5), pp.760~769 (2012)
26. Nantongo JS, "Variability of phenolic and alkaloid content in different plant parts of Carissa edulis Vahl and Zanthoxylum chalybeum Engl", BMC Res Notes, 11(1), pp.125~ (2018)
27. Jing L, "Antioxidant potential, total phenolic and total flavonoid contents of Rhododendron anthopogonoides and its protective effect on hypoxia-induced injury in PC12 cells", BMC Complement Altern Med, 15, pp.287~ (2015)
28. Hartanti L, "Influence of extraction methods of bay leaves(Syzygium polyanthum)on antioxidant and HMG-CoA reductase inhibitory activity", Heliyon, 5(4), pp.e01485~ (2019)
29. Ji X, "Bioactive compounds from herbal medicines to manage dyslipidemia", Biomed Pharmacother, 118, pp.109338~ (2019)
30. Strobel P, "Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes", Biochem J, 386(Pt 3), pp.471~478 (2005)
31. Kosowski M, "Impact of alirocumab on release markers of atherosclerotic plaque vulnerability in patients with mixed hyperlipidemia and vulnerable atherosclerotic plaque", Medicina(Kaunas), 58(7), pp.969~ (2022)
32. Sawant DA, "Regulation of tumor necrosis factor-α-induced microvascular endothelial cell hyperpermeability by recombinant B-cell lymphoma-extra large", J Surg Res, 184(1), pp.628~637 (2013)
33. Urschel K, "TNF-α in the cardiovascular system : from physiology to therapy", Int J Interf Cytokine Mediat Res, 7, pp.9~25 (2015)
34. Reiss AB, "Interleukin-6 in atherosclerosis : atherogenic or atheroprotective?", Clin Lipidol, 12(1), pp.14~23 (2017)
35. Jones SA, "C-reactive protein : a physiological activator of interleukin 6 receptor shedding", J Exp Med, 189(3), pp.599~604 (1999)
36. Carty CL, "Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study", Ann Hum Genet, 74(1), pp.1~10 (2010)
37. Kang S, "IL-6 trans-signaling induces plasminogen activator inhibitor-1from vascular endothelial cells in cytokine release syndrome", Proc Natl Acad Sci U S A, 117(36), pp.22351~22356 (2020)
38. Zhang Y, "IL(interleukin)-6 contributes to deep vein thrombosis and is negatively regulated by miR-338-5p", Arterioscler Thromb Vasc Biol, 40(2), pp.323~334 (2020)
39. Giovinazzo G, "Can natural polyphenols help in reducing cytokine storm in COVID-19patients?", Molecules, 25(24), pp.5888~ (2020)
40. Al-Khayri JM, "Flavonoids as potential anti-inflammatory molecules : a review", Molecules, 27(9), pp.2901~ (2022)

관련 논문AI추천